Journal article

Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer

Jianneng Li, Mohammad Alyamani, Ao Zhang, Kai-Hsiung Chang, Michael Berk, Zhenfei Li, Ziqi Zhu, Marianne Petro, Cristina Magi-Galluzzi, Mary-Ellen Taplin, Jorge A Garcia, Kevin Courtney, Eric A Klein, Nima Sharifi

eLife | ELIFE SCIENCES PUBLICATIONS LTD | Published : 2017

University of Melbourne Researchers

Grants

Awarded by U.S. Department of Defense


Awarded by National Cancer Institute


Awarded by American Cancer Society


Awarded by NATIONAL CANCER INSTITUTE


Awarded by NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES


Funding Acknowledgements

U.S. Department of Defense W81XWH-16-1-0270 Jianneng LiProstate Cancer Foundation Zhenfei Li Nima SharifiNational Cancer Institute R01CA168899 Nima SharifiAmerican Cancer Society 12-038-01-CCE Nima SharifiNational Cancer Institute R01CA172382 Nima SharifiNational Cancer Institute R01CA190289 Nima SharifiHoward Hughes Medical Institute Nima SharifiThe funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.